A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders.
The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease.
Developing treatments for CNS disease.
Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine.
A private biopharmaceutical company focusing on DNA repair technology, dermatology, liposome diagnosis, skin cancer research and early cancer diagnosis and the lifestyle enhancement market.
Virtual pharmaceutical discovery and development company. Specialists in outsourced project and technology management.
A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term major product opportunities.
Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine.
|